Loading...
XJPX4204
Market cap6.51bUSD
Dec 24, Last price  
2,448.00JPY
1D
0.74%
1Q
9.29%
Jan 2017
31.33%
Name

Sekisui Chemical Co Ltd

Chart & Performance

D1W1MN
XJPX:4204 chart
P/E
13.12
P/S
0.81
EPS
186.64
Div Yield, %
2.72%
Shrs. gr., 5y
-1.86%
Rev. gr., 5y
1.92%
Revenues
1.26t
+1.13%
856,935,000,000885,067,000,000926,163,000,000958,674,000,000934,225,000,000858,514,000,000915,492,000,000965,090,000,0001,032,431,000,0001,110,851,000,0001,112,748,000,0001,096,317,000,0001,065,776,000,0001,107,429,000,0001,142,713,000,0001,129,254,000,0001,056,560,000,0001,157,945,000,0001,242,521,000,0001,256,538,000,000
Net income
77.93b
+12.51%
22,286,000,00020,229,000,00025,538,000,00024,300,000,0001,013,000,00011,627,000,00023,574,000,00028,116,000,00030,174,000,00041,190,000,00052,995,000,00056,653,000,00060,850,000,00063,459,000,00066,093,000,00059,181,000,00041,544,000,00037,067,000,00069,263,000,00077,930,000,000
CFO
106.63b
+49.05%
48,694,000,00038,268,000,00041,929,000,00031,782,000,00035,611,000,00074,983,000,00064,197,000,00066,652,000,00071,016,000,00097,720,000,00067,760,000,00071,389,000,000108,229,000,00082,272,000,00085,213,000,00092,647,000,00075,271,000,000105,023,000,00071,543,000,000106,632,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Jan 28, 2025

Profile

Sekisui Chemical Co., Ltd. engages in housing, urban infrastructure and environmental products (UIEP), high-performance plastics (HPP), and medical businesses. The Housing segment engages in the manufacturing, construction, sale, refurbishing, and other operations related to unit housing, real estate, and residential service business. The UIEP segment manufactures, constructs, and sells PVC pipes and joints, polyethylene pipes and joints, pipe and drain renewal materials and construction methods, reinforced plastic pipe, construction materials, and fiber-reinforced foamed urethane. The HPP segment engages in the manufacture and sale of interlayer films for laminated glass, polyolefin foam, tape, LCD fine particles and photosensitive materials, functional resin for infrastructure, diagnostic drugs, and other products. The Medical segment manufactures and sells diagnostic reagents, analyzers, pharmaceutical ingredients, and intermediates. It operates in Japan, the United States, Europe, Asia, and internationally. The company was formerly known as Sekisui Sangyo Co., Ltd. and changed its name to Sekisui Chemical Co., Ltd. in 1948. Sekisui Chemical Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.
URL
https://www.sekisui.co.jp/
IPO date
Mar 01, 1953
Employees
26,838
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,256,538,000
1.13%
1,242,521,000
7.30%
1,157,945,000
9.60%
Cost of revenue
1,203,839,000
1,135,919,000
1,054,945,000
Unusual Expense (Income)
NOPBT
52,699,000
106,602,000
103,000,000
NOPBT Margin
4.19%
8.58%
8.90%
Operating Taxes
32,424,000
28,726,000
31,098,000
Tax Rate
61.53%
26.95%
30.19%
NOPAT
20,275,000
77,876,000
71,902,000
Net income
77,930,000
12.51%
69,263,000
86.86%
37,067,000
-10.78%
Dividends
(27,830,000)
(23,816,000)
(21,532,000)
Dividend yield
2.94%
2.92%
2.75%
Proceeds from repurchase of equity
(16,173,000)
(35,082,000)
(6,867,000)
BB yield
1.71%
4.30%
0.88%
Debt
Debt current
17,032,000
8,725,000
9,293,000
Long-term debt
126,545,000
132,403,000
133,433,000
Deferred revenue
4,000
43,631,000
42,613,000
Other long-term liabilities
49,274,000
8,220,000
5,975,000
Net debt
(123,513,000)
(126,851,000)
(167,279,000)
Cash flow
Cash from operating activities
106,632,000
71,543,000
105,023,000
CAPEX
(60,455,000)
(56,407,000)
(44,614,000)
Cash from investing activities
(18,515,000)
(59,430,000)
2,694,000
Cash from financing activities
(53,023,000)
(62,906,000)
(54,729,000)
FCF
(38,025,000)
8,892,000
61,327,000
Balance
Cash
138,572,000
101,080,000
144,534,000
Long term investments
128,518,000
166,899,000
165,471,000
Excess cash
204,263,100
205,852,950
252,107,750
Stockholders' equity
760,981,000
1,300,620,000
1,250,712,000
Invested Capital
786,657,900
687,162,050
598,110,250
ROIC
2.75%
12.12%
11.66%
ROCE
5.29%
11.88%
12.05%
EV
Common stock shares outstanding
424,727
435,097
445,701
Price
2,230.00
18.87%
1,876.00
6.65%
1,759.00
-17.22%
Market cap
947,141,210
16.04%
816,241,972
4.11%
783,988,059
-18.37%
EV
852,223,210
1,346,930,972
1,257,237,059
EBITDA
105,371,000
159,008,000
151,704,000
EV/EBITDA
8.09
8.47
8.29
Interest
1,103,000
871,000
774,000
Interest/NOPBT
2.09%
0.82%
0.75%